2-Methylthiazole-5-Carboxylic Acid Ethyl Ester

In continuous multi-purpose API manufacturing suites operating under ICH Q7 Chapter 12 campaign production protocols, the role of heterocyclic ester intermediates demands rigorous batch lineage documentation. 2-Methylthiazole-5-carboxylic acid ethyl ester functions as a strategic C-5 functionalized thiazole building block for constructing the pharmacophoric core of triazole-class antimycotic agents. The synthetic pathway involves initial ester hydrolysis under alkaline conditions — typically employing 2.0–3.5 M aqueous sodium hydroxide in a methanol/water co-solvent system within a glass-lined reactor (DIN 28136-compliant, 3,000–6,300 L working volume) maintained at 55–65 °C with controlled exotherm management via jacket cooling at ΔT ≤ 8 °C/min ramp rate. The liberated carboxylic acid intermediate undergoes subsequent CDI-mediated (1,1′-carbonyldiimidazole) activation in anhydrous tetrahydrofuran at –5 to 0 °C, followed by condensation with a substituted benzylamine moiety to construct the final triazole scaffold. Typical molar incorporation of the thiazole ester relative to the final API molecular weight ranges from 18–24% on a mass-equivalent basis, with the ester contributing to the critical heme-binding domain responsible for lanosterol 14α-demethylase (CYP51) inhibition. Batch records require HPLC purity ≥ 99.3% (area normalization, USP <621> methodology, C18 column, acetonitrile/0.1% trifluoroacetic acid gradient) with single impurity thresholds not exceeding 0.15% for any unspecified individual contaminant per ICH Q3A guidelines. Residual solvent analysis by headspace GC-FID must demonstrate ethyl acetate and methanol levels below 5,000 ppm and 3,000 ppm respectively, aligned with ICH Q3C Class 2 and Class 3 solvent limits. The downstream formulation into finished dosage forms — predominantly lyophilized powders for reconstitution (50 mg and 200 mg vial presentations) or film-coated tablets (150 mg strength) — requires particle size distribution control of the micronized intermediate via jet milling (Malvern Mastersizer 3000, D90 ≤ 15 µm) to ensure content uniformity meeting USP <905> acceptance criteria. Avoid storage under nitrogen purge with residual oxygen levels exceeding 1.5% — hydrolytic ring-opening of the thiazole moiety has been documented in stability chambers at 40 °C/75% RH over 6-month accelerated protocols when exposed to moisture ingress through compromised container closure systems (LDPE liner failure mode observed in field returns). The terminal product class encompasses prescription-only triazole antifungal APIs indicated for invasive aspergillosis and candidemia, regulated under FDA 21 CFR Part 211 subpart D (equipment design) and Part 211 subpart I (laboratory controls), with EU GMP Annex 15 qualification requirements applied to the solvent recovery distillation skids integral to the manufacturing workflow.

Aggressive fungal pathogens affecting high-value row crops — notably Rhizoctonia solani in soybean, Botrytis cinerea in grapevine, and Fusarium graminearum in wheat — have driven demand for thiazole-carboxamide fungicides exhibiting non-cross-resistant modes of action relative to strobilurin and SDHI chemistries. In dedicated agricultural chemical synthesis plants operating under ISO 9001:2015 quality management frameworks with supplementary hazard analysis per OSHA 29 CFR 1910.119 (Process Safety Management of Highly Hazardous Chemicals), ester-amine coupling constitutes the pivotal bond-forming step. The transformation proceeds via direct amidation of 2-methylthiazole-5-carboxylic acid ethyl ester with 4-(trifluoromethyl)aniline derivatives in refluxing toluene (110–115 °C system temperature) catalyzed by 0.08–0.12 molar equivalents of titanium(IV) isopropoxide, achieving conversion rates exceeding 94% as monitored by inline ReactIR analysis of the carbonyl stretching frequency shift from 1,712 cm⁻¹ (ester) to 1,658 cm⁻¹ (amide). The molar feed ratio of the thiazole ester intermediate to the amine coupling partner is maintained at 1.03:1.00 to ensure complete consumption of the costlier fluorinated aryl component, with the excess ester recovered during post-reaction thin-film evaporation (Buchi-type, 0.5–2.0 mbar operating vacuum, rotor speed 300–450 rpm) and re-qualified for re-use up to three consecutive campaigns before chromatographic repurification becomes necessary. Final formulated products — typically emulsifiable concentrate (EC) formulations at 250 g/L active ingredient loading, or water-dispersible granule (WG) presentations at 50% w/w — must comply with FAO Specification 409/EC (for EC formulations) and CIPAC Handbook J analytical methods for suspension stability, wet sieve retention (≤ 2.0% on a 75 µm test sieve per CIPAC MT 185), and persistent foam volume (≤ 25 mL after 1 min per CIPAC MT 47.2). The thiazole ester constitutes approximately 35–42% of the downstream active ingredient molecular weight, with the ethyl ester group serving as a pro-moiety that modulates log P within the optimal 2.8–3.5 range for translaminar movement in dicotyledonous leaf tissue. Published data for this specific amidation configuration under continuous flow conditions (Corning Advanced-Flow Reactor G1 module) indicates a 12-fold reduction in reaction residence time compared to batch mode, though industrial adoption rates remain constrained by catalyst fouling on borosilicate reactor plates beyond 800 hours of cumulative runtime.

What governs the oxidative stability of the thiazole ring during high-shear melt compounding with polyamide matrices?

Incorporation of heterocyclic ester additives into engineering thermoplastics for metal-deactivation and anti-corrosion functionality necessitates scrutiny of thermal degradation thresholds during twin-screw extrusion. When 2-methylthiazole-5-carboxylic acid ethyl ester is dosed as a modifier into polyamide 6,6 (PA66) — processed on a Leistritz ZSE 27 MAXX co-rotating twin-screw extruder with 40:1 L/D ratio, barrel zones programmed from 240 °C (feed throat) to 285 °C (die plate), screw speed 350–500 rpm — the primary failure mode involves thiazole ring scission at temperatures exceeding 290 °C, generating sulfur-containing volatiles that corrode downstream calibration tooling fabricated from P20 tool steel. Thermogravimetric analysis (TGA, ASTM E1131-20, nitrogen atmosphere, 10 °C/min ramp) of the neat ester reveals a 5% mass loss onset at 178 °C and a decomposition inflection point at 244 °C, establishing a processing window no wider than ±12 °C relative to the PA66 melt temperature setpoint. Addition levels of 0.3–0.8% w/w — introduced via a gravimetric side-feeder (Brabender DSR28) into the melt zone at barrel segment 6 — require pre-compounding masterbatch dilution to 5% active concentration in a PA6 carrier resin (MFI 18 g/10 min at 235 °C/2.16 kg, ISO 1133-1:2022) to achieve acceptable dispersive mixing homogeneity. Optical microscopy of microtomed sections (Leica RM2265 rotary microtome, 15 µm section thickness) at 200× magnification confirms the absence of agglomerates exceeding 10 µm diameter when the masterbatch let-down ratio is maintained above 6:1. Compliance testing of the compounded material against IEC 60754-2 (determination of acidity and conductivity of gases evolved during combustion) yields conductivity values of ≤ 2.5 µS/mm and pH ≥ 4.3, confirming the suitability of the modified compounds for halogen-free flame-retardant cable jacketing applications governed by EU Construction Products Regulation (EU) No. 305/2011. However, combination with nitrogen-phosphorus synergistic flame retardants (specifically melamine polyphosphate grades) is contraindicated: phosphoric acid species released during combustion catalyze thiazole hydrolysis at 300–350 °C via an autocatalytic mechanism, leading to accelerated char formation that embrittles the intumescent residue and compromises its thermal insulation function as measured by cone calorimetry (ISO 5660-1, 50 kW/m² irradiance). The terminal product category covers industrial cable management systems, automotive under-hood electrical connectors (validated per USCAR-2 Rev. 7 for vibration endurance and thermal shock), and corrosion-resistant fasteners requiring continuous service at 150 °C for 3,000 hours per ISO 9227 neutral salt spray testing without red rust formation on embedded steel substrates.

Within the domain of fragrance compounding for consumer packaged goods, 2-methylthiazole-5-carboxylic acid ethyl ester occupies a narrow but established niche as a precursor in the synthesis of thiazoline and thiazolidine odorants exhibiting roasted, nutty, and toasted cereal organoleptic profiles. The compound is processed in dedicated odorant synthesis suites compliant with IFRA Practice Guidelines (51st Amendment) and the IOFI Code of Practice for the flavor industry, operating under EN 1672-2:2020 hygienic design requirements when destined for food-adjacent fragrance applications. Transformation into the active aroma chemical follows a two-step sequence: controlled partial reduction of the thiazole ester using 1.05 equivalents of diisobutylaluminium hydride (DIBAL-H, 1.0 M in hexanes) at –78 °C under argon atmosphere in a jacketed stainless-steel reactor (Ekato Paravisc agitator, 120 rpm) yields the corresponding aldehyde, which is then condensed with cysteine methyl ester hydrochloride in pH 7.2 phosphate-buffered aqueous ethanol (50% v/v) to form the thiazolidine heterocycle responsible for the characteristic roasted peanut and coffee note. The final compounded fragrance oil — containing the thiazolidine derivative at 0.05–0.5% w/w of the total formula — is evaluated according to IFRA Category 4 (hydroalcoholic products for use on unshaved skin) exposure assessment, with dermal sensitization quantitative risk assessment (QRA) demonstrating acceptable no-expected-sensitization-induction levels (NESIL) at ≤ 110 µg/cm². Analytical release specifications require chiral GC analysis (CycloSil-B column, 30 m × 0.25 mm ID, 0.25 µm film thickness) confirming diastereomeric ratios of the thiazolidine product within ≥ 95:5 for the cis-configured isomer, as the trans-isomer imparts an undesirable burnt-rubber off-note detectable at threshold concentrations as low as 12 ppb in aqueous sucrose solutions (ASTM E679-19 forced-choice ascending concentration series method). The finished goods spectrum includes fine fragrance eaux de parfum (ethanol-water base, 12–18% fragrance loading), fabric softener sheet coatings (nonwoven substrate impregnation at 0.02–0.08% fragrance retention on dry fabric), and microwave popcorn flavor systems where the thiazolidine analog functions as a character-impact compound simulating butter-toasted notes without the diacetyl exposure concerns addressed in EU Regulation (EC) No. 1272/2008 Annex VI toxicological classifications.

Insulin Sensitizer Scaffold Construction: Ester Hydrolysis and Thiazolidinedione Heterocycle Assembly

Process chemistry for thiazolidinedione-class insulin-sensitizing agents utilizes 2-methylthiazole-5-carboxylic acid ethyl ester as the five-membered heterocycle donor in a convergent assembly strategy distinct from the linear synthesis employed in triazole antimycotic manufacturing. The C-5 ester group undergoes quantitative saponification to the carboxylic acid in a binary solvent system composed of tetrahydrofuran and deionized water (3:1 v/v) containing lithium hydroxide monohydrate (1.2 molar equivalents) at ambient temperature (20–25 °C) over 4–6 hours, as tracked by TLC (silica gel 60 F254 plates, ethyl acetate/hexanes 1:1 mobile phase, R_f carboxylic acid = 0.05, R_f ester = 0.65). The crude acid is isolated by pH-adjusted extraction into aqueous sodium bicarbonate followed by acidification to pH 2.0–2.5 with 6 M HCl and filtration through a Nutsche filter (sintered glass, porosity 3) with –0.6 bar vacuum applied. Subsequent activation with thionyl chloride (1.5 equivalents, 0–5 °C, catalytic DMF) and coupling with 2,4-thiazolidinedione under basic conditions (triethylamine, 1.8 equivalents in dichloromethane) constructs the key carbon-carbon bond at the 5-position of the thiazole ring. The molar contribution of the thiazole ester to the final thiazolidinedione drug substance approximates 28–33% by molecular weight. Purification of the coupled intermediate via recrystallization from ethyl acetate/n-heptane (1:3 v/v, 5 mL/g solvent ratio, cooling from 70 °C to 5 °C at 0.2 °C/min controlled ramp) achieves > 99.7% HPLC purity with residual palladium levels — from an earlier Suzuki-Miyaura cross-coupling step on the thiazole 2-position — measured at < 5 ppm by ICP-MS (Agilent 7900, m/z 105 and 106 monitored) per ICH Q3D Elemental Impurities Guideline for a parenteral maximum daily dose of 10 g. Published data for this specific configuration is limited regarding continuous manufacturing implementation; however, batch processing on 500–1,500 kg scale has been documented in publicly filed Drug Master Files referencing Type III DMF submissions for the thiazole ester as a regulatory starting material designated by the drug substance marketing authorization holder. Processing incompatibilities include exposure to strong oxidizing agents (hypochlorite, permanganate), which induce sulfoxidation at the thiazole sulfur atom generating a reactive electrophilic species capable of irreversible covalent binding to glutathione in in vitro microsomal stability assays (human liver microsomes, NADPH cofactor, 37 °C, 60 min incubation).

When Reaction Calorimetry Dictates the Safe Operating Envelope for Thiazole-Derived Neonicotinoid Bioisosteres

Isosteric replacement of the chloropyridinyl moiety in neonicotinoid insecticides with a 2-methylthiazole-5-carbonyl group represents a scaffold-hopping strategy documented in structure-activity relationship studies targeting nicotinic acetylcholine receptor (nAChR) subtype selectivity against Myzus persicae (green peach aphid) and Bemisia tabaci (silverleaf whitefly). The ethyl ester intermediate is first reduced to the primary alcohol using 2.2 equivalents of lithium aluminium hydride in anhydrous diethyl ether at 0–5 °C under rigorously anhydrous conditions (Karl Fischer titration ≤ 50 ppm water equivalent), an operation that demands reaction calorimetry (Mettler Toledo RC1e, 1 L Hastelloy C276 reaction vessel) to characterize an exotherm of –285 ± 15 kJ/mol with an adiabatic temperature rise (ΔT_ad) of 127 °C for the undiluted reaction mass. The resultant hydroxymethyl thiazole intermediate is activated as the methanesulfonate ester (methanesulfonyl chloride, 1.1 equivalents, triethylamine 1.3 equivalents in dichloromethane at –10 °C) and subjected to nucleophilic displacement with imidazolidine or thiazolidine nitromethylene nucleophiles to complete the bioisosteric scaffold. Pilot-plant execution (200–500 L glass-lined reactor, Pfaudler WL series, three-stage Ekato INTERMIG impeller, 90–120 rpm) requires semi-batch addition of the hydride reducing agent over 90–120 minutes with jacket temperature maintained at –15 °C circulating brine to prevent thermal runaway, a procedural safeguard derived from adiabatic calorimetry (Phi-Tec II ARC, 10 °C bomb, phi-factor 1.05) indicating onset of an uncontrolled decomposition exotherm at 88 °C on thermal ramp simulation. The final formulated insecticide — typically presented as a 200 g/L soluble concentrate (SL) or 20% wettable powder (WP) — must conform to the CIPAC MT 75.3 method for persistent foaming (≤ 60 mL after 1 min for SL formulations) and CIPAC MT 161 for suspensibility in CIPAC Standard Water D (hardness 342 ppm as CaCO₃). The thiazole ester contributes 22–28% of the active substance molecular weight, with modifications at the 2-methyl position — specifically bromine radical-initiated substitution under Wohl-Ziegler conditions (N-bromosuccinimide, 0.95 equivalents, benzoyl peroxide initiator 1.0 mol% in carbon tetrachloride at reflux) — enabling further derivatization to modulate log P within the range 0.8–1.6 required for phloem mobility in systemic applications. Stored intermediates with residual moisture content above 0.3% w/w exhibit a 3–5% per month degradation rate at 25 °C ambient storage in HDPE drums, attributed to autocatalytic ester hydrolysis accelerated by the slightly acidic nature of the thiazole ring (calculated pK_a of conjugated acid ≈ 1.8).

Catalytic hydrogenation of the thiazole ring to the corresponding thiazolidine — a transformation occasionally required for generating saturated heterocycle precursors in central nervous system drug discovery programs — introduces a processing constraint documented across multiple kilo-lab campaigns. The reaction, conducted in a Parr Series 4560 bench-top stirred reactor (600 mL Hastelloy C276 vessel, magnetically driven gas-entrainment impeller at 1,200–1,500 rpm), employs 5% rhodium-on-alumina catalyst (Johnson Matthey Type 5R328, 10 mol% Rh relative to substrate) under 50–60 bar hydrogen pressure in glacial acetic acid at 45–50 °C. Reaction progression is monitored by hydrogen uptake curves reaching a plateau of 2.0–2.1 molar equivalents of H₂ absorbed. Catalyst poisoning by organosulfur species liberated during ring saturation — identified via X-ray photoelectron spectroscopy (XPS) as thiolate-bound Rh(0) surface species with S 2p binding energies at 162.3 eV — necessitates catalyst replacement after three consecutive batches regardless of apparent retained activity by hydrogenation rate metrics. The saturated thiazolidine ester exhibits markedly different stability characteristics: hydrolytic half-life in pH 1.2 simulated gastric fluid (USP <711>, Apparatus 2, 37 °C, 50 rpm paddle speed) decreases to 18 hours compared to > 72 hours for the parent aromatic thiazole ester. This differential stability profile governs the decision tree for whether the reduction is performed at the intermediate stage or deferred to a post-coupling step later in the synthetic sequence, with the former route preferred when the final active pharmaceutical ingredient contains a reduction-sensitive functional group that would be incompatible with heterogeneous hydrogenation conditions. Terminal finished goods from this synthetic stream include gabapentinoid analogs in Phase II clinical evaluation (oral capsules, 100 mg and 300 mg dose strengths, packed in Al/Al cold-form blister cavities with desiccant sachets complying with USP <671> moisture vapor transmission rate specifications of ≤ 0.5 mg/day per cavity).